The Effect of Coronary Revascularization on New-Onset Complete Atrioventricular Block Due to Acute Coronary Syndrome
Background: Coronary artery disease is one of the most common causes of complete atrioventricular block (AVB) in adults. In this study, we evaluated whether prompt revascularization of the coronary artery occlusion can ameliorate new-onset complete AVB due to acute coronary syndrome (ACS).
Methods: Five patients (4 men and 1 woman) with a mean age of 69.8 ± 7.1 years with diagnosed new-onset complete AVB and proven coronary artery disease were enrolled in the study. At the time of AVB diagnosis, 3 of the patients had acute myocardial infarction, and the other 2 patients had unstable angina pectoris. All patients underwent complete coronary bypass surgery after the diagnosis of complete AVB. A patient who underwent 2 coronary bypasses also underwent aortic valve replacement.
Results: No mortality was observed in the study group. All but one of the patients converted back to sinus rhythm after a mean interval of 30 ± 13.6 hours following revascularization procedures. Complete AVB persisted in 1 patient, and a permanent pacemaker was implanted. All patients were discharged uneventfully. The mean hospital stay was 11.4 ± 4.5 days. All patients are still being followed up after surgery; at a mean follow-up of 27.4 ± 0.9 months, there have been no further problems.
Conclusion: Coronary revascularization may ameliorate ACS-related new-onset complete AVB with an acceptable rate of successful reversion to sinus rhythm. An especially appropriate time for surgery, complete coronary revascularization, and management of myocardial protection during surgery might improve the results of coronary bypass procedures in these patients.
Archbold RA, Sayer JW, Ray S, Wilkinson P, Ranjadayalan K, Timmis AD. 1998. Frequency and prognostic implications of conduction defects in acute myocardial infarction since the introduction of thrombolytic therapy. Eur Heart J 19:893-8.nCeviz M, Koçak H, Ba?o?lu A, et al. 1995. Post-CABG conduction disturbances. Ann Thorac Surg 59:546-7.nCook DJ, Bailon JM, Douglas TT, et al. 2005. Changing incidence, type, and natural history of conduction defects after coronary artery bypass grafting. Ann Thorac Surg 80:1732-7.nEagle KA, Guyton RA, Davidoff R, et al. 2004. ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1999 Guidelines for Coronary Artery Bypass Graft Surgery). Circulation 110:1168-76.nEscosteguy CC, Carvalho MA, Medronho RA, Abreau LM, Monteiro Filho MY. 2001. Bundle branch and atrioventricular block as complications of acute myocardial infarction in the thrombolytic era. Arq Bras Cardiol 76:291-6.nFlack JE 3rd, Hafer J, Engelman RM, Rousou JA, Deaton DW, Pekow P. 1992. Effect of normothermic blood cardioplegia on postoperative conduction abnormalities and supraventricular arrhythmias. Circulation 86(suppl):II385-92.nHarpaz D, Behar S, Gottlieb S, Boyko V, Kishon Y, Eldar., for the SPRINT Study Group and the Israeli Thrombolytic Survey Group. 1999. Complete atrioventricular block complicating acute myocardial infarction in the thrombolytic era. J Am Coll Cardiol 34:1721-8.nHippeläinen M, Mustonen P, Manninen H, Rehnberg S. 1994. Predictors of conduction disturbances after coronary bypass grafting. Ann Thorac Surg 57:1284-7.nKimura K, Kosuge M, Ishikawa T, et al. 1999. Comparison of results of early reperfusion in patients with inferior wall acute myocardial infarction with and without complete atrioventricular block. Am J Cardiol 84:731-3.nLim CH, Toh CC, Low LP. 1971. Atrioventricular and associated intraventricular conduction disturbances in acute myocardial infarction. Br Heart J 33:947-54.nMeine TJ, Al-Khatib SM, Alexander JH, et al. 2005. Incidence, predictors, and outcome of high-degree atrioventricular block complicating acute myocardial infarction treated with thrombolytic therapy. Am Heart J 149:670-4.nMoreyra AE, Horvitz L, Presant SB, Kostis JB. 1988. Resolution of complete heart block after right coronary artery angioplasty Am Heart J 115:179-81.nMosseri M, Izak T, Rosenheck S, et al. 1997. Coronary angiographic characteristics of patients with permanent artificial pacemakers. Circulation 96:809-15.nMustonen P, Hippeläinen M, Vanninen E, Rehnberg S, Tenhhunen-Eskelinen, Hartikainen J. 1998. Significance of coronary artery bypass grafting-associated conduction defects. Am J Cardiol 81:558-63.nMustonen P, Pöyhönen M, Rehnberg S, et al. 2000. Conduction defects after coronary artery bypass grafting—a disappearing problem? Ann Chir Gynaecol 89:33-9.nNicod P, Gilpin E, Dittrich H, et al. 1998. Long-term outcome in patients with inferior myocardial infarction and complete atrioventricular block. J Am Coll Cardiol 12:589-94.nOkmen E, Gurol T, Erdinler I, Sanli A, Cam N. 2003. New-onset conduction defects and their relationship with in-hospital major cardiac events in unstable angina pectoris. Coron Artery Dis 14:521-5.nOmeroglu SN, Ardal H, Erdogan HB, et al. 2005. Can revascularization restore sinus rhythm in patients with acute onset atrioventricular block? J Card Surg 20:136-41.nOpolski G, Kraska T, Ostrzycki A, Zieli?ski T, Korewicki J. 1986. The effect of infarct size on atrioventricular and intraventricular conduction disturbances in acute myocardial infarction. Int J Cardiol 10:141-7.nPartington MT, Acar C, Buckberg GD, Julia PL. 1989. Studies of retrograde cardioplegia. II. Advantages of antegrade/retrograde cardioplegia to optimize distribution in jeopardized myocardium. J Thorac Cardiovasc Surg 97:613-22.nRamamurthy S, Anandaraja S, Matthew N. 2007. Percutaneous coronary intervention for persistent complete heart block complicating inferior myocardial infarction. J Invasive Cardiol 19:E372-4.nRathore SS, Gersh BJ, Berger PB, et al. 2001. Acute myocardial infarction complicated by heart block in the elderly: prevalence and outcomes. Am Heart J 141:47-54.n
How to Cite
Author Disclosure & Copyright Transfer Agreement
In order to publish the original work of another person(s), The Heart Surgery Forum® must receive an acknowledgment of the Author Agreement and Copyright Transfer Statement transferring to Forum Multimedia Publishing, L.L.C., a subsidiary of Carden Jennings Publishing Co., Ltd. the exclusive rights to print and distribute the author(s) work in all media forms. Failure to check Copyright Transfer agreement box below will delay publication of the manuscript.
A current form follows:
The author(s) hereby transfer(s), assign(s), or otherwise convey(s) all copyright ownership of the manuscript submitted to Forum Multimedia Publishing, LLC (Publisher). The copyright transfer covers the exclusive rights to reproduce and distribute the article and the material contained therein throughout the world in all languages and in all media of expression now known or later developed, including but not limited to reprints, photographic reproduction, microfilm, electronic data processing (including programming, storage, and transmission to other electronic data record(s), or any other reproductions of similar nature), and translations.
However, Publisher grants back to the author(s) the following:
- The right to make and distribute copies of all or part of this work for use of the author(s) in teaching;
- The right to use, after publication in The Heart Surgery Forum, all or part of the material from this work in a book by the author(s), or in a collection of work by the author(s);
- The royalty-free right to make copies of this work for internal distribution within the institution/company that employs the author(s) subject to the provisions below for a work-made-for-hire;
- The right to use figures and tables from this work, and up to 250 words of text, for any purpose;
- The right to make oral presentations of material from this work.
Publisher reserves the right to grant or refuse permission to third parties to republish all or part of the article or translations thereof. To republish, such third parties must obtain written permission from the Publisher. (This is in accordance with the Copyright Statute, United States Code, Title 17. Exception: If all authors were bona fide officers or employees of the U.S. Government at the time the paper was prepared, the work is a “work of the US Government” (prepared by an officer or employee of the US Government as part of official duties), and therefore is not subject to US copyright; such exception should be indicated on signature lines. If this work was prepared under US Government contract or grant, the US Government may reproduce, royalty-free, all or portions of this work and may authorize others to do so, for official US Government purposes only, if the US Government contract or grant so requires.
I have participated in the conception and design of this work and in the writing of the manuscript and take public responsibility for it. Neither this manuscript nor one with substantially similar content under my authorship has been published, has been submitted for publication elsewhere, or will be submitted for publication elsewhere while under consideration by The Heart Surgery Forum, except as described in an attachment. I have reviewed this manuscript (original version) and approve its submission. If I am listed above as corresponding author, I will provide all authors with information regarding this manuscript and will obtain their approval before submitting any revision. I attest to the validity, accuracy, and legitimacy of the content of the manuscript and understand that Publisher assumes no responsibility for the validity, accuracy, and legitimacy of its content. I warrant that this manuscript is original with me and that I have full power to make this Agreement. I warrant that it contains no matter that is libelous or otherwise unlawful or that invades individual privacy or infringes any copyright or other proprietary right. I agree to indemnify and hold Publisher harmless of and from any claim made against Publisher that relates to or arises out of the publication of the manuscript and agree that this indemnification shall include payment of all costs and expenses relating to the defense of any such claim, including all reasonable attorney’s fees.
I warrant that I have no financial interest in the drugs, devices, or procedures described in the manuscript (except as disclosed in the attached statement).
I state that the institutional Human Subjects Committee and/or the Ethics Committee approved the clinical protocol reported in this manuscript for the use of experimental techniques, drugs, or devices in human subjects and appropriate informed consent documents were utilized.
Furthermore, I state that any and all animals used for experimental purposes received humane care in USDA registered facilities in compliance with the “Principles of Laboratory Animal Care” formulated by the National Society for Medical Research and the “Guide for the Care and Use of Laboratory Animals” prepared by the Institute of Laboratory Animal Resources and published by the National Institutes of Health (NIH Publication No. 85-23, revised 1985).